Study Emphasizes PSMA PET Staging of High-Risk, Hormone Sensitive Prostate Cancer
In patients with high-risk, hormone sensitive prostate cancer who had no evidence of metastasis on conventional imaging, PSMA PET revealed polymetastatic disease in 24 percent of patients and M1 disease staging in 46 percent of patients.
Multicenter Study Shows Merits of AI-Powered Ultrasound Assessment for Detecting Ovarian Cancer
Adjunctive AI offered greater than seven percent increases in sensitivity, specificity, and accuracy for ultrasound detection of ovarian cancer in comparison to unassisted clinicians who lacked ultrasound expertise, according to findings from new international multicenter research.
Can MRI and Micro-Ultrasound Guidance Bolster Focal Laser Ablation Outcomes for Prostate Cancer?
For patients with localized prostate cancer and PI-RADS 3 or higher lesions, MRI-guided micro-ultrasound multifiber focal laser ablation had an 18 percent recurrence rate at one year, according to newly published research.
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
In the third part of a three-part interview from the recent RSNA conference, Mark Traill, M.D., discusses the potential of image-based risk assessment artificial intelligence (AI) algorithms in bolstering adherence to screening protocols for women at high risk for breast cancer.
New CT and MRI Research Shows Link Between LR-M Lesions and Rapid Progression of Early-Stage HCC
Seventy percent of LR-M hepatocellular carcinoma (HCC) cases were associated with rapid growth in comparison to 12.5 percent of LR-4 HCCs and 28.5 percent of LR-4 HCCs, according to a new study.
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 2
In the second part of a three-part interview from the recent RSNA conference, Mark Traill, M.D., emphasizes patience and monitoring with the assessment of AI to ensure optimal use of the technology to help ease the strain of increasing breast imaging volume.